August 22, 2014 4:14 PM ET

Biotechnology

Company Overview of Pervasis Therapeutics, Inc.

Company Overview

Pervasis Therapeutics, Inc., a clinical-stage company, engages in the development and commercialization of endothelial cell-based therapies to regulate the body’s natural healing and repair processes in various critical therapeutic areas. It focuses on developing therapies to improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stent placements, and peripheral and coronary bypass grafts. The company also engages in developing an oncology therapy focused on preventing solid tumor growth, cancer recurrence, and metastatic disease; and products for inflammatory disease and orthopedic injury. Its product pipeline includes Vascugel, a therapeutic for...

One Kendall Square

Suite B6101

Cambridge, MA 02139

United States

Founded in 2003

Phone:

617-621-3407

Fax:

617-621-3408

Key Executives for Pervasis Therapeutics, Inc.

Co-Founder and Director
Age: 65
Co-Founder and Advisor
Age: 65
Director of Business Administration
Senior Vice President of Strategy & Corporate Development
Age: 42
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
PSMA Development Company L.L.C. United States
Valley Organics Inc. United States
Osprey Biomedical Corp. United States
REGENX Biosciences, LLC United States
Bio-Bridge Science Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pervasis Therapeutics, Inc., please visit www.pervasistx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.